Market News

Policy shifts rattled wound care sales, but sequential growth hints at stabilization.

Full capacity returns, but Q4 pricing faces a sizable headwind.

PCTY combines strong growth, high profitability, low debt and a bull flag with pocket pivot, making it a technically confirmed growth-screen candidate...

Susquehanna analyst Bascome Majors maintains GXO Logistics (NYSE:GXO) with a Positive and raises the price target from $60 to $66.

TSMC stock rose nearly 7% premarket after Taiwan tightened short-selling rules and readied a $15 billion fund to stem a semiconductor selloff.

For months, investors have been worrying about a long list of risks to the gravy train of artificial intelligence spending.

IREN Limited remains a Sell as dilution and debt risks grow despite AI cloud revenue gains. Click here for this IREN stock update.

Susquehanna analyst James Friedman maintains Genpact (NYSE:G) with a Neutral and raises the price target from $40 to $42.

Union Pacific reported strong Q3 2026 results, with revenue and EPS up 15%, but underlying freight revenue growth was only 6%. Read why UNP stock is a...

https://www.sec.gov/Archives/edgar/data/1920406/000095010326017073/dp256456_424b3-sata.htm

Susquehanna analyst James Friedman maintains Shift4 Payments (NYSE:FOUR) with a Positive and lowers the price target from $63 to $56.

Bloomin' Brands stock fell Friday despite topping Q3 estimates. Weak traffic and a soft Q4 outlook weighed on investor sentiment.

Scotiabank analyst John Zamparo downgrades Gildan Activewear (NYSE:GIL) from Sector Outperform to Sector Perform and lowers the price target from $...

ARS Pharma missed Q3 earnings and sales estimates; shares rose 5.6% premarket as analysts cut price targets despite neffy progress.

Needham analyst David Saxon maintains Globus Medical (NYSE:GMED) with a Buy and lowers the price target from $117 to $100.

Susquehanna analyst Shyam Patil maintains Expedia Group (NASDAQ:EXPE) with a Neutral and lowers the price target from $315 to $310.

Strong earnings couldn't shield Micron and AMD when chip stocks buckled, and the market's fear gauge sat calm the day before. Behind the blame on poli...

Susquehanna analyst James Friedman maintains EPAM Systems (NYSE:EPAM) with a Positive and raises the price target from $146 to $190.

Needham analyst Austin Bohlig maintains Karman Holdings (NYSE:KRMN) with a Buy and lowers the price target from $80 to $50.